Building a new conceptual framework for receptor heteromers.

Receptor heteromers constitute a new area of research that is reshaping our thinking about biochemistry, cell biology, pharmacology and drug discovery. In this commentary, we recommend clear definitions that should facilitate both information exchange and research on this growing class of transmembrane signal transduction units and their complex properties. We also consider research questions underlying the proposed nomenclature, with recommendations for receptor heteromer identification in native tissues and their use as targets for drug development.

[1]  Graeme Milligan,et al.  Identification of a serotonin/glutamate receptor complex implicated in psychosis , 2008, Nature.

[2]  P P Humphrey,et al.  International Union of Pharmacology. XIX. The IUPHAR receptor code: a proposal for an alphanumeric classification system. , 1998, Pharmacological reviews.

[3]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.

[4]  David J. Daniels,et al.  Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jamie Fong,et al.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Chao,et al.  Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.

[7]  K. Eidne,et al.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.

[8]  Arthur Christopoulos,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology , 2003, Pharmacological Reviews.

[9]  P. Sexton,et al.  GPCR modulation by RAMPs. , 2006, Pharmacology & therapeutics.

[10]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[11]  K. Fuxe,et al.  Identification of Dopamine D1–D3 Receptor Heteromers , 2008, Journal of Biological Chemistry.

[12]  M. Zoli,et al.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance. , 2006, Trends in pharmacological sciences.

[13]  Luigi F Agnati,et al.  Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons , 2003, Pharmacological Reviews.

[14]  R. Jockers,et al.  Do orphan G‐protein‐coupled receptors have ligand‐independent functions? , 2006, EMBO reports.

[15]  Michel Bouvier,et al.  Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.

[16]  Gemma Navarro,et al.  Detection of heteromerization of more than two proteins by sequential BRET-FRET , 2008, Nature Methods.

[17]  M. Salter.  D1 and NMDA receptors hook up: expanding on an emerging theme , 2003, Trends in Neurosciences.

[18]  Marta Filizola,et al.  Dopamine D2 receptors form higher order oligomers at physiological expression levels , 2008, The EMBO journal.

[19]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[20]  Krzysztof Palczewski,et al.  Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer* , 2008, Journal of Biological Chemistry.

[21]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[22]  K. Mackie,et al.  Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.

[23]  G. Milligan,et al.  Allosteric modulation of heterodimeric G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[24]  B. O'dowd,et al.  D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum , 2007, Proceedings of the National Academy of Sciences.

[25]  F. Ciruela,et al.  Functional relevance of neurotransmitter receptor heteromers in the central nervous system , 2007, Trends in Neurosciences.

[26]  K. Lorenz,et al.  Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. , 2008, Nature chemical biology.

[27]  Michel Bouvier,et al.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.

[28]  K. Fuxe,et al.  Dimer-based model for heptaspanning membrane receptors. , 2005, Trends in biochemical sciences.

[29]  Michel Bouvier,et al.  Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. , 2004, Proceedings of the National Academy of Sciences of the United States of America.